PharmaLogic Executive and Leadership Team

Etienne Montagut, the President & Chief Executive Officer at PharmaLogic, directs the overarching corporate strategy and operational execution for the global contract development and manufacturing organization. Montagut guides the company's expansion in diagnostic and therapeutic radiopharmaceuticals, ensuring alignment with market demands and pharmaceutical partner objectives. This leadership involves overseeing the network of radiopharmacies and manufacturing facilities across North America and Europe, driving the development, manufacturing, and distribution of critical radiopharmaceutical products. By fostering innovation and strategic partnerships, Etienne Montagut ensures PharmaLogic maintains its position as a key provider to healthcare systems and pharmaceutical clients, ultimately impacting patient care through advanced radiopharmaceutical solutions. The executive's focus remains on sustainable growth and enhancing the company's capabilities in a highly specialized sector.

Mark Dmytruk, the Chief Financial Officer at PharmaLogic, oversees all financial planning, management, and reporting for the global contract development and manufacturing organization. Dmytruk directs financial strategy, ensuring robust fiscal health and supporting the company's growth initiatives in the radiopharmaceutical sector. This involves managing capital allocation, optimizing financial performance across North American and European operations, and maintaining strong relationships with financial stakeholders. By providing critical financial insights, Mark Dmytruk enables informed decision-making regarding investments in manufacturing capabilities and product development. The Chief Financial Officer's purview includes risk management and ensuring compliance with financial regulations, thereby safeguarding the company's assets and supporting its long-term strategic objectives in serving pharmaceutical partners and healthcare providers.

Glen Palmer, the Chief Operating Officer at PharmaLogic, manages the day-to-day operational activities critical to the company's global reach. Palmer oversees the integrated network of radiopharmacies and manufacturing sites spanning North America and Europe, ensuring efficient production and distribution of radiopharmaceutical products. This role involves optimizing supply chain logistics and manufacturing processes to meet the stringent quality and regulatory standards required for diagnostic and therapeutic agents. By driving operational excellence, Glen Palmer supports the company's mission to deliver vital radiopharmaceuticals to pharmaceutical partners and healthcare providers. The Chief Operating Officer's responsibilities extend to enhancing operational efficiency and scalability across all facilities, directly contributing to PharmaLogic's capacity to serve a growing global market and maintain its leadership in radiopharmaceutical manufacturing.

Timothy Quinton, the President at PharmaLogic, drives key commercial and strategic initiatives for the global contract development and manufacturing organization. Quinton focuses on expanding market reach and strengthening relationships with pharmaceutical partners and healthcare providers across North America and Europe. This role involves identifying new business opportunities and ensuring the effective distribution of diagnostic and therapeutic radiopharmaceuticals. By championing commercial strategies, Timothy Quinton supports the company's mission to deliver essential radiopharmaceutical products. The President's leadership is instrumental in translating scientific advancements into market-ready solutions, contributing significantly to PharmaLogic's growth and its impact on patient care through innovative radiopharmaceutical services.

Hallie Pierson, the Chief People Officer at PharmaLogic, leads human capital strategy and organizational development across the company's global operations. Pierson is responsible for attracting, developing, and retaining top talent within the specialized field of radiopharmaceutical manufacturing and development. This involves cultivating a strong corporate culture that supports innovation and collaboration across the network of radiopharmacies and manufacturing facilities in North America and Europe. By focusing on employee engagement and professional growth, Hallie Pierson ensures PharmaLogic has the skilled workforce necessary to meet the complex demands of its pharmaceutical partners and healthcare providers. The Chief People Officer's strategic initiatives are vital for building a high-performing team dedicated to advancing the company's mission in delivering critical radiopharmaceutical products.

Pamela Wong, the Chief Legal Officer at PharmaLogic, provides comprehensive legal counsel and oversees all legal affairs for the global contract development and manufacturing organization. Wong manages corporate governance, regulatory compliance, and intellectual property matters critical to the radiopharmaceutical industry. This leadership ensures that PharmaLogic's operations across North America and Europe adhere to all relevant legal frameworks governing the development, manufacturing, and distribution of diagnostic and therapeutic radiopharmaceuticals. By mitigating legal risks and advising on strategic initiatives, Pamela Wong supports the company's partnerships with pharmaceutical clients and its service to healthcare providers. The Chief Legal Officer's expertise is essential for navigating the complex regulatory landscape and safeguarding the company's interests as it expands its market presence.